Last reviewed · How we verify
NCT04422977: SEROPHUGAC
Serological Study of the Exposure of Personnel to COVID-19
NA trial testing Sars-Cov-2 serology in Sars-CoV2 in 957 participants. Completed in 10 July 2020.
10 July 2020
Quick facts
| Lead sponsor | Centre Hospitalier Saint Joseph Saint Luc de Lyon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 957 |
| Start date | 8 June 2020 |
| Primary completion | 10 July 2020 |
| Estimated completion | 10 July 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Sars-Cov-2 serology
Conditions studied
- Sars-CoV2 — all drugs for Sars-CoV2 →
Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Who can join
Adults 18 to 70, any sex, with Sars-CoV2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine: * whether the subject has shown signs of infection in the last 3 recent months * if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague) * Working conditions during the period * The level of knowledge and respect of the barrier measures practices. * Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital.
Vivier E, Vivier E, Pariset C, Rio S, et al · · 2021 · cited 2× · PMID 33987718 · DOI 10.1186/s13613-021-00868-8
Verify or expand the search:
- PubMed search for NCT04422977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sars-CoV2
Currently open trials in the same condition.
- NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
- NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
- NCT04363853 — Tocilizumab Treatment in Patients With COVID-19 · Phase 2 · active not recruiting
- NCT04424992 — The Natural History of Hospitalized COVID-19 Patients · recruiting
Other Centre Hospitalier Saint Joseph Saint Luc de Lyon trials
Trials by the same sponsor.
- NCT07312890 — Bedside Observation by Clinical Ultrasound for Stomach Expansion · NA · recruiting
- NCT07355777 — Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation · NA · recruiting
- NCT04827290 — Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease · NA · not yet recruiting
- NCT04641650 — Pilot Study : FreeStyle Libre Pro Flash Continuous Glucose Monitoring System in Subjects With Diabetes on HemoDIALsis · completed
- NCT04221282 — ZEBinix® Retention Rate in Epilepsy in Elderly Patients · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04422977 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Saint Joseph Saint Luc de Lyon
- Last refreshed: 4 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04422977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing